A Pilot Study of Stable Kidney Transplant Recipients Taking Tacrolimus With CNS Symptoms Switched to Envarsus
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Oct 2019
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 29 Apr 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Apr 2018 Status changed from not yet recruiting to recruiting.